Current techniques in screening for cervical cancer in Spain: Updated recommendations

Gynecologic Oncology

Volumn 110, Issue 3 SUPPL.2, 2008, Pages

  Puig Tintoré, Luis M ^a   Torné, Aureli ^a   Alonso, Immaculada ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cervical cancer; Cytology; HPV testing; Pap smear; Screening; Spain

Indexed keywords

ARTICLE; CANCER RISK; CANCER SCREENING; CONSENSUS; CYTOLOGY; HEALTH SURVEY; HUMAN; MEDICAL SOCIETY; PAPANICOLAOU TEST; PRIORITY JOURNAL; RURAL AREA; SOCIOECONOMICS; SPAIN; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RURAL POPULATION; SOCIOECONOMIC FACTORS; SPAIN; UTERINE CERVICAL NEOPLASMS;

EID: 50049136467     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.05.013     Document Type: Article

References (10)

1. IARC. Handbooks of cancer prevention. Cervix cancer screening (2005), IARC Press, Lyon
2. Bray F., Loos A.H., McCarron P., Weiderpass E., Arbyn M., Møller H., et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14 (2005) 677-686
3. de Sanjosé S., Alejo M., Combalia N., Culubret M., Tarroch X., Badal J.M., et al. Screening history in women with infiltrating uterine cancer. Gac Sanit 20 (2006) 166-170 (in Spanish)
4. Puig-Tintoré L.M., Castellsague X., Torne A., de Sanjose S., Cortes J., Roura E., et al. Coverage and factors associated with cervical cancer screening: results from the AFRODITA study, a population-based survey in Spain. J Low Genit Tract Dis 12 (2008) 82-89
5. Luengo Matos S., and Muñoz V.D.E.A. Use of Pap test for cervical cancer screening and factors related with use in Spain. Aten Primaria 33 (2004) 229-236
6. Font R., Lloveras B., Olivera M., Falguera G., Planes A., et al. Population estimate on the frequency of screening for cervical cancer. Model for the attraction and rapid intervention in bad screened women. Central Region, Catalonia. Gaceta Sanitaria 19 suppl 3 (2005) 82 (in Spanish)
7. Puig-Tintoré L.M., Cortés J., Castellsague X., Torne A., Ordi J., de Sanjose S.S., et al. Prevención del cáncer de cuello uterino, ante la vacunación frente al virus del papiloma humano. Prog Obstet Ginecol 49 suppl 2 (2006) 5-62
8. Vilaplana E., Puig-Tintoré L.M., and Cortés J. Resultados citológicos anormales, encuesta española. Comunicación previa. Boletín AEPCC (2006) 20:10 (in Spanish)
9. Arbyn M., Sasieni P., Meijer C.J.L.M., Clavel C., Koliopoulos G., and Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 suppl 3 (2006) S78-S89
10. Bulkmans N.W., Berkhof J., Rozendaal L., Folkert J., van Kemenade F.J., Boeke S., et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370 (2007) 1764-1772